GTR 115116310
Tenders Are Invited For Infliximab Injection Powder For Reconstitution 100Mg Each Vial To Contain 100Mg Of Infliximab (A Chimeric Human-Murine Immunoglobulin Monoclonal Antibody) Manufactured From Recombinant Cell Culture As A Powder For Reconstitution For Intravenous Infusion.
ICB — International Competitive Bid
Closes Aug 10, 2026
Asia
Tender Information
GTR Reference
115116310
Tendering Authority
Subscribe to view
Tender No
DHS/P/C/ICB/08/2027
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Infliximab Injection Powder For Reconstitution 100Mg Each Vial To Contain 100Mg Of Infliximab (A Chimeric Human-Murine Immunoglobulin Monoclonal Antibody) Manufactured From Recombinant Cell Culture As A Powder For Reconstitution For Intravenous Infusion.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
South Asian Association for Regional Cooperation (SAARC),APAC (Asia Pacific)
Last Date of Bid Submission
10-08-2026
Work Detail
Tenders Are Invited For Infliximab Injection Powder For Reconstitution 100Mg Each Vial To Contain 100Mg Of Infliximab (A Chimeric Human-Murine Immunoglobulin Monoclonal Antibody) Manufactured From Recombinant Cell Culture As A Powder For Reconstitution For Intravenous Infusion.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
782e1d32-13f7-401d-ac7b-ba032831a6a5.pdf
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.